CEL-SCI CORPORATION Notes and Loans Payable, Current
CEL-SCI CORPORATION (CVM) had Notes and Loans Payable, Current of $0 as of 2018-09-30, per its 10-K filed 2018-12-19.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:NotesAndLoansPayableCurrent · last filed 2018-12-19
- 2018-09-30: Notes and Loans Payable, Current $0.00.
- 2018-06-30: Notes and Loans Payable, Current $0.00.
- 2018-03-31: Notes and Loans Payable, Current $1.18M.
- 2017-12-31: Notes and Loans Payable, Current $874.59K.
| Period end | Notes and Loans Payable, Current |
|---|---|
| 2018-09-30 | $0.00 10-K · filed 2018-12-19 |
| 2018-06-30 | $0.00 10-Q · filed 2018-08-14 |
| 2018-03-31 | $1.18M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $874.59K 10-Q · filed 2018-02-12 |
| 2017-09-30 | $994.26K 10-K · filed 2018-12-19 |
| 2017-06-30 | $325.79K 10-Q/A · filed 2017-12-11 |
| 2016-09-30 | $0.00 10-K · filed 2017-12-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |